Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 583 | 1,259 | N/A | 1,552 |
| TOTAL | $734 | $1,451 | $N/A | $1,622 |
| Non-Current Assets | ||||
| Investments And Advances | 166,815 | 166,809 | 0 | 166,762 |
| TOTAL | $166,815 | $166,809 | $N/A | $166,762 |
| Total Assets | $167,549 | $168,261 | $N/A | $168,384 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 26 | 68 | 0 | 5 |
| Accrued Expenses | 293 | 210 | N/A | 74 |
| TOTAL | $355 | $302 | $N/A | $115 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 156,358 | 157,122 | 0 | 157,432 |
| TOTAL | $162,194 | $162,959 | $N/A | $163,269 |
| Total Liabilities | $162,549 | $163,261 | $N/A | $163,384 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 21,377 | 21,377 | 21,377 | 21,377 |
| Common Shares | 1 | 1 | N/A | 1 |
| Retained earnings | -1,127 | -363 | N/A | -53 |
| TOTAL | $5,000 | $5,000 | $N/A | $5,000 |
| Total Liabilities And Equity | $167,549 | $168,261 | $0 | $168,384 |